We are live on
!
Find out more
BI
Boulegeris Investments Portfolio holdings
AUM
$200M
1-Year Est. Return
7%
This Fund
S&P 500
This Quarter
Est. Return
+1.56%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
+$4.13M
(+3%)
Cap. Flow
+$4M
Cap. Flow
% of AUM
2.82%
Top 10 Holdings %
Top 10 Hldgs %
67.85%
Holding
53
New
6
Increased
32
Reduced
11
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNR
Monmouth Real Estate Investment Corp
MNR
|
+$1.44M |
| 2 |
McDonald's
MCD
|
+$660K |
| 3 |
SIR
SELECT INCOME REIT
SIR
|
+$652K |
| 4 |
PepsiCo
PEP
|
+$604K |
| 5 |
Johnson & Johnson
JNJ
|
+$408K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPG Industries
PPG
|
+$1.08M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$542K |
| 3 |
Novartis
NVS
|
+$490K |
| 4 |
NNN REIT
NNN
|
+$320K |
| 5 |
Wells Fargo
WFC
|
+$270K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 32.45% |
| 2 | Healthcare | 24.06% |
| 3 | Consumer Staples | 8.54% |
| 4 | Consumer Discretionary | 6.39% |
| 5 | Technology | 5.49% |
Similar funds
ACM
SSM
PCM
OA
XGI
MGA
MFP
ESG
Boulegeris Investments's Q1 2016 Portfolio in Review
As of Q1 2016, Boulegeris Investments held 53 positions worth $142M, up 3% from $138M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Boulegeris Investments's Q1 2016 filing shows 6 new, 32 increased, 11 reduced and 1 closed positions. Its largest new stake was McDonald's: 5,520 shares worth $694K. The largest sale was PPG Industries, an estimated $1.08M.
By sector, the portfolio is most concentrated in Real Estate at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Staples.
- Boulegeris Investments's largest Q1 2016 buy was McDonald's: 5,520 shares worth $694K.
- Boulegeris Investments added most to Monmouth Real Estate Investment Corp in Q1 2016, an estimated $1.44M increase.
- Boulegeris Investments's biggest Q1 2016 reduction was PPG Industries, cutting an estimated $1.08M.
- Boulegeris Investments fully exited BioMarin Pharmaceuticals in Q1 2016, selling an estimated $542K.
- Boulegeris Investments's ten largest holdings make up 68% of its $142M portfolio in Q1 2016.
- Boulegeris Investments opened 6 new positions and closed 1 in Q1 2016.
- Boulegeris Investments's portfolio value rose 3% quarter-over-quarter to $142M.
Based on Boulegeris Investments's 13F filing for Q1 2016, filed 5 May 2016.